JOHN A SCHINKA
Psychologist at Warren Rd, Lutz, FL
License number
Florida 2576
Issued Date
Mar 5, 1982
Effective Date
Jun 15, 2016
Expiration Date
May 31, 2016
Category
Health Care
Type
Psychologist
Address
Address
703 Warren Rd, Lutz, FL 33548
Phone
(813) 949-2664
Professional information
Dr. John A Schinka, Lutz FL - PHD
Specialties:
Neuropsychology, Clinical Neuropsychology
Address:
703 Warren Rd, Lutz 33548
(813) 972-2000 (Phone)
(813) 972-2000 (Phone)
Languages:
English
Method And Assay For Diagnosing Substance Dependency
US Patent:
2004004, Mar 11, 2004
Filed:
Aug 11, 2003
Appl. No.:
10/638571
Inventors:
Terence Town - Tampa FL, US
Laila Abdullah - Tampa FL, US
Michael Mullan - Tampa FL, US
John Schinka - Lutz FL, US
Laila Abdullah - Tampa FL, US
Michael Mullan - Tampa FL, US
John Schinka - Lutz FL, US
International Classification:
C12Q001/00
US Classification:
435/004000
Abstract:
There is provided an assay for assessing the risk for developing substance dependency, including alcohol, opiate, cocaine, marijuana having a screening device for screening samples for the OPRM1+118A allele polymorphism, the presence of the allele indicating a risk of developing substance dependency. A method for diagnosing the risk for developing substance dependency by screening samples for the OPRM1+118A allele, whereby the presence of the allele indicates substance dependence is also provided. Also provided is a marker for determining the risk of developing substance dependency having an allele indicating the risk for developing substance dependency.
Method And Assay For Diagnosing Substance Dependency
US Patent:
2002000, Jan 17, 2002
Filed:
Jul 2, 2001
Appl. No.:
09/898566
Inventors:
Terence Town - Tampa FL, US
Laila Abdullah - Tampa FL, US
Michael Mullan - Tampa FL, US
John Schinka - Lutz FL, US
Laila Abdullah - Tampa FL, US
Michael Mullan - Tampa FL, US
John Schinka - Lutz FL, US
International Classification:
C12Q001/68, G01N033/543
US Classification:
435/006000, 436/518000
Abstract:
There is provided an assay for assessing the risk for developing substance dependency, including alcohol, opiate, cocaine, marijuana having a screening device for screening samples for the OPRM1+118A allele polymorphism, the presence of the allele indicating a risk of developing substance dependency. A method for diagnosing the risk for developing substance dependency by screening samples for the OPRM1+118A allele, whereby the presence of the allele indicates substance dependence is also provided. Also provided is a marker for determining the risk of developing substance dependency having an allele indicating the risk for developing substance dependency.